Director's Dealing • Feb 12, 2021
Director's Dealing
Open in ViewerOpens in native device viewer
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
Details of the person discharging managerial responsibilities/person closely associated Name Thomas Videbæk
| Position/status | Executive Vice President, | +1 919 702 6144 |
|---|---|---|
| Strategy & Business Transformation; People, Sustainability & Brand | [email protected] | |
| Initial notification/ | Initial notification | Ulrik Wu Svare |
| amendment | +45 3077 3187 | |
| Entity | Novozymes A/S |
|---|---|
| LEI code | 529900T6WNZXD2R3JW38 |
| Description: | |||
|---|---|---|---|
| Financial instrument | Shares | ||
| Identification code | ISIN DK0060336014 | ||
| Nature of the transaction | Exercise of share options (purchase) | ||
| Place(s) of transaction(s), | Place(s) | Price(s) | Volume(s) |
| price(s) and volume(s) | Novozymes' custody account |
249.40 | 60,960 shares |
| Aggregated information | Number of shares: 60,960 Average price, DKK: 249.40 Transaction value, DKK: 15,203,424 |
||
| Date of the transaction | 2021-02-11 (10:11:00 CET) |
Contact information [email protected]
Tobias Cornelius Björklund +45 3077 8682 [email protected]
Carl Ahlgren
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38
Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark
Phone: +45 4446 0000
Name Thomas Videbæk
| Position/status | Executive Vice President, |
|---|---|
| Strategy & Business Transformation; People, Sustainability & Brand | |
| Initial notification/ | Initial notification |
| amendment |
| Entity | Novozymes A/S |
|---|---|
| LEI code | 529900T6WNZXD2R3JW38 |
| Description: | |||
|---|---|---|---|
| Financial instrument | Shares | ||
| Identification code | ISIN DK0060336014 | ||
| Nature of the transaction | Sale of shares | ||
| Place(s) of transaction(s), | |||
| price(s) and volume(s) | Place(s) | Price(s) | Volume(s) |
| See appendix | See appendix | See appendix | |
| Aggregated information | Number of shares: 60,960 | ||
| Average price, DKK: 397.00 | |||
| Transaction value, DKK: 24,201,135.61 | |||
| Date of the transaction | 2021-02-11 |
| Volume | Price | Venue |
|---|---|---|
| 60708 | 397 | Off Exchange |
| 96 | 397.1 | Citi Match |
| 60 | 397.1 | Citi Match |
| 96 | 397 | Citidel Connect Europe |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.